Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Payments (Details) - Schedule of options were granted

v3.23.1
Share-Based Payments (Details) - Schedule of options were granted - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 10,508,991 26,407,764
Incentive Equity Plan [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 2,295,099 23,915,248
Grant date 01/01/2022 01/10/2021
Expiry date 01/01/2032 01/10/2031
Incentive Equity Plan One [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 1,269,100  
Grant date 01/04/2022  
Expiry date 01/04/2032  
Incentive Equity Plan Two [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 1,087,250  
Grant date 01/07/2022  
Expiry date 01/07/2032  
Incentive Equity Plan Three [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 427,300  
Grant date 01/10/2022  
Expiry date 01/10/2032  
Incentive Equity Plan – Directors [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 3,933,339  
Grant date 01/10/2022  
Expiry date 01/10/2032  
SAYE [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number 1,496,903  
Grant date 26/01/2022  
Expiry date 31/08/2025  
Unapproved prior to the Transaction [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number   469,000
Grant date   01/01/2021
Expiry date   01/01/2031
Unapproved prior to the Transaction One [Member]    
Share-Based Payments (Details) - Schedule of options were granted [Line Items]    
Number   2,023,516
Grant date   01/04/2021
Expiry date   01/04/2031